Literature DB >> 1132315

[Chromosome investigations in subjects with occupational lead exposure (author's transl)].

G Schwanitz, E Gebhart, H D Rott, K H Schaller, H G Essing, O Lauer, H Prestele.   

Abstract

The lead content in blood, the excretion of delta-aminolaevulinic acid (ALA) in urine, and the ratio of secondary chromosomal aberrations in lymphocyte cultures were investigated in 105 workers with varying degrees of lead exposure. While the mean lead content was slightly increased (377 plus or minue 207 mug/l) the mean ALA excretion was normal (3,8 plus or minus 4.7 mg/g creatine). Chromosome investigations showed a slightly increased rate of cells with structural abnormalities (14,1 plus or minus 7.0%). Statistical evaluation of these data showed no significant correlation between the lead content in blood, ALA excretion in urine, and cytogenetic findings. No other reason for the increased rate of chromosomal aberrations could be detected.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1132315     DOI: 10.1055/s-0028-1106327

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Absence of an effect of lead acetate on sperm morphology, sister chromatid exchanges or on micronuclei formation in rabbits.

Authors:  M I Willems; G G de Schepper; A A Wibowo; H R Immel; A J Dietrich; R L Zielhuis
Journal:  Arch Toxicol       Date:  1982-07       Impact factor: 5.153

2.  Temporary increase in chromosome breakage in an infant prenatally exposed to lead.

Authors:  Q H Qazi; C Madahar; A M Yuceoglu
Journal:  Hum Genet       Date:  1980-02       Impact factor: 4.132

Review 3.  Chromosome aberrations and their relevance to metal carcinogenesis.

Authors:  H Vainio; M Sorsa
Journal:  Environ Health Perspect       Date:  1981-08       Impact factor: 9.031

Review 4.  Role of cobalt, iron, lead, manganese, mercury, platinum, selenium, and titanium in carcinogenesis.

Authors:  G Kazantzis
Journal:  Environ Health Perspect       Date:  1981-08       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.